Vimta Labs LtdHealthcare Research- Analytics and TechnologyINE579C01029Standalone₹603.10+3.50 (+0.58%)Jun-26
Valuation
Market Cap₹2.69K Cr
TTM PE33.77x
Forward PE33.76x
PEG12.79
Book Value₹102.28
P/B5.90x
TTM EPS₹17.86
Fwd EPS₹17.87
TTM Revenue₹418.80 Cr
TTM PAT₹79.66 Cr
TTM EBITDA₹145.14 Cr
TTM EBIT₹98.68 Cr
Last Qtr PAT₹21.04 Cr
Last Qtr EBITDA₹37.31 Cr
Last Qtr EBIT₹24.76 Cr
Profitability
ROE17.44%
ROCE23.00%
TTM NPM19.02%
TTM EBITDA %34.66%
Curr OPM18.64%
Last OPM18.85%
Curr NPM—
Last NPM—
Curr EPS₹4.71
Last EPS₹4.73
Balance sheet
Equity₹8.93 Cr
Reserve₹447.94 Cr
Total Debt₹3.33 Cr
D/E0.01x
Interest %1.14%
Curr Interest₹0.24 Cr
Price / range
Close₹603.10
vs 52W High-29.13%
vs 52W Low+59.85%
MA50—
MA200—
Returns
1D+0.58%
1W-4.21%
1M-2.91%
3M+6.35%
6M+39.36%
1Y-23.76%
2Y+110.30%
3Y+123.16%
5Y+321.66%
Diwali+0.55%
Sector peers — Healthcare Research- Analytics and Technology
| Company | Close | Mkt Cap | TTM P/E | ROE |
|---|
| SYNGENE | 369.05 | ₹14.90K Cr | 64.86 | 4.73% |
| INDGN | 600.10 | ₹14.46K Cr | 63.57 | 7.22% |
| SUVEN | 341.55 | ₹9.65K Cr | -141.72 | -9.50% |
| VIMTALABS | 603.10 | ₹2.69K Cr | 33.77 | 17.44% |
| BI | 109.14 | ₹256.97 Cr | -162.90 | — |
| TAKE | 15.96 | ₹236.10 Cr | 38.93 | 18.87% |
| JSTL | 81.25 | ₹161.84 Cr | 25.79 | — |
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits